Arcturus Therapeutics (ARCT) PT Lowered to $65 at Leerink Partners

March 7, 2025 5:47 AM

Leerink Partners analyst Lili Nsongo lowered the price target on Arcturus Therapeutics (NASDAQ: ARCT) to $65.00 (from $70.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found